AF
SPPI

Amalgamated Financial’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Amalgamated Financial’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$34K Buy
+26,544
New +$24.4K ﹤0.01% 2583

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Amalgamated Financial's SPPI Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022: 26,544 shares worth $34K. The stake represents ﹤0.01% of the portfolio and ranks #2583 among its holdings.

101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Amalgamated Financial held 26,544 shares of Spectrum Pharmaceuticals Inc worth $34K as of Q1 2022.
  • Spectrum Pharmaceuticals Inc was a new Amalgamated Financial position in Q1 2022.
  • Spectrum Pharmaceuticals Inc made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2583 holding.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.